← Back to Search

Magnetogastrogram for Gastroparesis

N/A

Waitlist Available

Led By Leonard A Bradshaw, PhD

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Children (ages 12-17) with functional dyspepsia

Total or partial gastrectomy patients

Must not have

Patients with a history of cardiac arrhythmias, taking anticoagulants, or greater than 80 years of age will be excluded

Normal participants with known intestinal complications

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Summary

This trial is looking at a new way to assess bioelectrical activity in the gastrointestinal system in order to help characterize normal and pathologic physiology of the stomach.

Who is the study for?

This trial is for people aged 12-80 with conditions like gastroparesis, chronic nausea, or those who've had a gastrectomy. It includes diabetic patients and children with functional dyspepsia. Pregnant women, individuals over 80, those with claustrophobia, morbid obesity, cardiac arrhythmias or on anticoagulants cannot participate.

What is being tested?

The study tests a noninvasive technique called magnetogastrogram (MGG) to assess gastric electrical activity without radiation exposure. The goal is to distinguish normal from abnormal gastric activity which could improve treatment for stomach disorders.

What are the potential side effects?

Since MGG is noninvasive and doesn't involve drugs or radiation, significant side effects are not expected. However, the procedure requires lying still under equipment which might be uncomfortable for some participants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a child aged 12-17 with stomach upset not caused by any known disease.

Select...

I have had all or part of my stomach removed.

Select...

I am between 12 and 80 years old.

Select...

I have been diagnosed with idiopathic gastroparesis.

Select...

I am a child aged 12-17 with ongoing nausea.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have a history of heart rhythm problems, am not on blood thinners, and am under 80 years old.

Select...

I have known issues with my intestines but am otherwise healthy.

Select...

I am not pregnant or able to become pregnant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

5Treatment groups

Experimental Treatment

Group I: GastroparesisExperimental Treatment1 Intervention

magnetogastrogram Diabetes with and without gastroparesis ; Idiopathic gastroparesis

Group II: GastrectomyExperimental Treatment1 Intervention

magnetogastrogram Total or partial gastrectomy group

Group III: Functional dyspepsiaExperimental Treatment1 Intervention

magnetogastrogram Children with functional dyspepsia

Group IV: Control participantsExperimental Treatment1 Intervention

magnetogastrogram Group without any gastrointestinal diseases.

Group V: Chronic nauseaExperimental Treatment1 Intervention

magnetogastrogram Children with chronic nausea

0 / 8Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

888 Previous Clinical Trials

934,784 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,410 Previous Clinical Trials

4,324,741 Total Patients Enrolled

19 Trials studying Gastroparesis

2,996 Patients Enrolled for Gastroparesis

Leonard A Bradshaw, PhDPrincipal InvestigatorVanderbilt University Medical Center

Media Library

magnetogastrogram Clinical Trial Eligibility Overview. Trial Name: NCT03176927 — N/A

Gastroparesis Research Study Groups: Gastroparesis, Gastrectomy, Functional dyspepsia, Chronic nausea, Control participants

Gastroparesis Clinical Trial 2023: magnetogastrogram Highlights & Side Effects. Trial Name: NCT03176927 — N/A

magnetogastrogram 2023 Treatment Timeline for Medical Study. Trial Name: NCT03176927 — N/A

~12 spots leftby Sep 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.